LOCATION

Encore at Wynn

Las Vegas, Nevada

Friday, September 14, 2018    |    6:15PM-7:15PM

DOWNLOADS

Will be available directly following the activity.

FACULTY

Daniel E. Furst, MD

Professor of Rheumatology,

University of Washington School
of Medicine

Seattle, Washington

David Geffen School of
Medicine at UCLA

Los Angeles, California

 

 

Linda Grinnell-Merrick,
MS, NP-BC

Nurse Practitioner,

Division of Allergy, Immunology,
and Rheumatology

University of Rochester
Medical Center

Rochester, New York

 

 

AGENDA

ACTIVITY AND CME INFORMATION

TARGET AUDIENCE

WORKSHOP DESCRIPTION

LEARNING OBJECTIVES

 

The target audience is rheumatologists and nurse practitioners and physician assistants who specialize in rheumatology. Other clinicians who treat patients with PsA may benefit from participation in this educational activity.

 

Steps Ahead: Emerging Therapies in Psoriatic Arthritis is a fast-paced workshop featuring real-life scenarios and discussions designed to provide new ideas, answers, and confidence in treating PsA. Through a series of presentations and exercises, attendees will cover a range of diagnosis and therapeutic options, opportunities, and outcomes to ultimately gain a deeper understanding on how to better address care gaps and move the treatment of PsA forward.

 

As a result of participation in this educational activity, participants should increase their ability to:

Optimize monitoring for adherence to treatment, achievement of treatment targets, adverse events, and comorbidities in patients with PsA.

Translate evidence-based recommendations and the latest research data related to use of DMARDs in PsA into clinically meaningful information for managing patients with PsA.

1.

2.

3.

Develop a patient-centered approach to coordination of PsA care between rheumatology and dermatology providers.

4.

Effectively engage patients with PsA in SDM regarding treatment goals, development of the treatment plan, and treatment modification.

CREDIT DESIGNATION STATEMENT

ACCREDITATION STATEMENT

 

DISCLOSURE STATEMENT

Forefront Collaborative designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Interstate Postgraduate Medical Association is approved by the California Board of Registered Nursing, Provider Number 6971, for 1.2 contact hours. Each person should retain this certificate for 4 years after the course has been completed. RNs outside of California must verify with their licensing agency for approval of this course.

 

This activity is approved for 1.00 contact hour(s) of continuing education (which includes .50 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 18083318.  This activity was planned in accordance with AANP CE Standards and Policies.

 

 

Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). The disclosures will be listed in the online resources.

 

 

 

 

6:15 pm - 7:15 pm

Welcome and Session Overview

 

Applying GRAPPA and ACR/NPF Recommendations

to Treatment of PsA in Routine Clinical Practice

Daniel E. Furst, MD

 

Simulation

 

Patient-Centered Care for Patients With Psoriasis and PsA

Linda Grinnell-Merrick, MS, NP-BC

 

Feedback & Discussion

 
Question and Answer Session

 

Closing Remarks

 

 

 

 

 

 

 

 

 

The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative, Interstate Postgraduate Medical Association, and Lilly.

This symposium is independently organized and not an official part of The 11th Perspectives in Rheumatic Diseases conference.

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Forefront Collaborative complies with the Americans with Disabilities Act and will make every reasonable effort to accommodate your request. For special requests, please call Christine Tebben at 317.208.2768 prior to this activity.

630 W. Carmel Drive, Suite 260

Carmel, Indiana 46032

Friday,
September 14, 2018

6:15PM-7:15PM